We have been recognized as a leader company because of the quality of our products and the great investments in Research & Development Boehringer Ingelheim is part of the Boehringer Ingelheim Corporation, a research-driven group of companies dedicated to serving humankind by researching, developing, manufacturing and marketing pharmaceuticals that improve health and quality of life. Boehringer Ingelheim was founded in Ingelheim, Germany, in 1885. We are one of the 20 most important pharmaceutical companies worldwide, with more than 142 affiliated companies in 47 countries and almost 37,500 employees. MODERN PHARMACEUTICAL PRODUCTION FACILITIES Our industrial complex in Mexico has a production capacity of 140 million units per year. This complex includes a modern facility for the production of solid forms (tablets, capsules and coated tablets), a refurbished facility for the production of liquid forms (syrups, solutions and creams), a quality assurance laboratory and a totally automated warehouse. Our industrial complex in Mexico has a production capacity of 140 million units per year. The following authorities certify our production facilities: FDA TPD SSA INVIMA ANVISA We can also offer our clients our experience on product transfer and production as well as the highest quality, a competitive price and flexibility Our installed production facilities include: Fluid bed dryers (Glatt) Grinders (Zanchetta) Tablets (Fette) Coated tablets (Brucks) Automatic coating units (Pellegrini) Capsule filling machines (Zanasi) Our plant includes an aluminum / PVC blister line (Marchesini, Gamma / Uhlmann), a bottled solid forms line (Kalish) and an aluminum / paper blister line (IMA). Our plant includes an aluminum / PVC blister line (Marchesini, Gamma / Uhlmann), a bottled solid forms line (Kalish) and an aluminum / paper blister lines (IMA). PRODUCTION OF SOLID DOSAGE FORMS Our dedicated facility for the production of solid dosage forms is equipped with state-of-the-art technology. It boasts three-level design. Gravity is used to vertically transport substances. This is done in a completely closed environment, from the third to the second level, and from the latter to the first level. This system eliminates the risk of contamination while simultaneously optimizing both time and movement. Many regulatory health authorities, like the FDA (USA), the TPD (Canada), the INVIMA of Colombia and the ANVISA of Brazil, have audited the solid dosage plant. Almost 50% of the production is exported directly to the USA and Canada. LIQUID DOSAGE FORMS Boehringer Ingelheim Promeco has a new and modern plant that is equipped for the exclusive production of liquids with the highest standards of quality. Our automated plant is highly flexible - one to three shifts, depending on customer production needs. Our liquid preparation unit can hold four 5,000L tanks, two 4,500L tanks and one 2,500L tank or a 500L cream-manufacturing unit (Moltomat). The packaging capacity at our liquid dosage forms plant includes: Bottled liquids filling lines of low and high dosage volume (IMA) Tubes filling / packaging line (Comadis) Manual packaging lines We have a production plant dedicated to solid dosage forms that is equipped with state-of-the-art technology. STRICT DOCUMENTATION OF PHARMACEUTICAL PRODUCTS Boehringer Ingelheim Promeco is a private and established pharmaceutical company that has fulfilled the most demanding market standards in the world, including those set by the FDA, the TPD, the SSA, the INVIMA and the ANVISA. We can offer modern and flexible facilities for the storage of finished goods. We can guarantee peace of mind with our strict documentation process, which enables our clients to follow up the production of their product step by step. Our knowledge of the American transportation system is also unsurpassed. Our production systems eliminate the risk of contamination while simultaneously optimizing both time and movement. Powered by Avni Media Pvt. Ltd.